Novaccess Global Stock Performance
| XSNX Stock | USD 0.0005 0.0004 400.00% |
NovAccess Global holds a performance score of 8 on a scale of zero to a hundred. The company secures a Beta (Market Risk) of -6.81, which conveys a somewhat significant risk relative to the market. As returns on the market increase, returns on owning NovAccess Global are expected to decrease by larger amounts. On the other hand, during market turmoil, NovAccess Global is expected to outperform it. Use NovAccess Global risk adjusted performance, information ratio, as well as the relationship between the Information Ratio and rate of daily change , to analyze future returns on NovAccess Global.
Risk-Adjusted Performance
Fair
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in NovAccess Global are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. In spite of fairly uncertain basic indicators, NovAccess Global showed solid returns over the last few months and may actually be approaching a breakup point. ...more
NovAccess |
NovAccess Global Relative Risk vs. Return Landscape
If you would invest 0.02 in NovAccess Global on October 29, 2025 and sell it today you would earn a total of 0.03 from holding NovAccess Global or generate 150.0% return on investment over 90 days. NovAccess Global is currently generating 5.7377% in daily expected returns and assumes 51.7191% risk (volatility on return distribution) over the 90 days horizon. In different words, most equities are less risky than NovAccess, and most traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
NovAccess Global Target Price Odds to finish over Current Price
The tendency of NovAccess Pink Sheet price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 0.0005 | 90 days | 0.0005 | near 1 |
Based on a normal probability distribution, the odds of NovAccess Global to move above the current price in 90 days from now is near 1 (This NovAccess Global probability density function shows the probability of NovAccess Pink Sheet to fall within a particular range of prices over 90 days) .
Given the investment horizon of 90 days NovAccess Global has a beta of -6.81. This entails as returns on its benchmark rise, returns on holding NovAccess Global are expected to decrease by similarly larger amounts. On the other hand, during market turmoils, NovAccess Global is expected to outperform its benchmark. In addition to that NovAccess Global has an alpha of 7.2913, implying that it can generate a 7.29 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta). NovAccess Global Price Density |
| Price |
Predictive Modules for NovAccess Global
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as NovAccess Global. Regardless of method or technology, however, to accurately forecast the pink sheet market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the pink sheet market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.NovAccess Global Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. NovAccess Global is not an exception. The market had few large corrections towards the NovAccess Global's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold NovAccess Global, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of NovAccess Global within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | 7.29 | |
β | Beta against Dow Jones | -6.81 | |
σ | Overall volatility | 0.000079 | |
Ir | Information ratio | 0.13 |
NovAccess Global Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of NovAccess Global for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for NovAccess Global can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| NovAccess Global is way too risky over 90 days horizon | |
| NovAccess Global has some characteristics of a very speculative penny stock | |
| NovAccess Global appears to be risky and price may revert if volatility continues | |
| NovAccess Global currently holds 165.88 K in liabilities. NovAccess Global has a current ratio of 0.04, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist NovAccess Global until it has trouble settling it off, either with new capital or with free cash flow. So, NovAccess Global's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like NovAccess Global sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for NovAccess to invest in growth at high rates of return. When we think about NovAccess Global's use of debt, we should always consider it together with cash and equity. | |
| Net Loss for the year was (1.72 M) with profit before overhead, payroll, taxes, and interest of 752.56 K. | |
| NovAccess Global currently holds about 89.94 K in cash with (903.49 K) of positive cash flow from operations. | |
| Roughly 53.0% of the company outstanding shares are owned by insiders |
NovAccess Global Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of NovAccess Pink Sheet often depends not only on the future outlook of the current and potential NovAccess Global's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. NovAccess Global's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 16.5 M | |
| Cash And Short Term Investments | 64.3 K |
NovAccess Global Fundamentals Growth
NovAccess Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of NovAccess Global, and NovAccess Global fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on NovAccess Pink Sheet performance.
| Return On Asset | -5.13 | |||
| Current Valuation | 5.75 M | |||
| Shares Outstanding | 19.57 M | |||
| Price To Earning | 2.69 X | |||
| Price To Sales | 2.87 X | |||
| EBITDA | (21.5 K) | |||
| Cash And Equivalents | 89.94 K | |||
| Total Debt | 165.88 K | |||
| Book Value Per Share | (0.50) X | |||
| Cash Flow From Operations | (903.49 K) | |||
| Earnings Per Share | (0.24) X | |||
| Total Asset | 124.9 K | |||
| Retained Earnings | (42.63 M) | |||
| Current Asset | 65 K | |||
| Current Liabilities | 791 K | |||
About NovAccess Global Performance
Evaluating NovAccess Global's performance through its fundamental ratios, provides valuable insights into its operational efficiency and profitability. For instance, if NovAccess Global has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if NovAccess Global has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
NovAccess Global Inc., a biopharmaceutical company, develops novel immunotherapies to treat brain tumor patients in the United States. NovAccess Global Inc. was incorporated in 1997 and is headquartered in Chesterland, Ohio. Novaccess Global operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 2 people.Things to note about NovAccess Global performance evaluation
Checking the ongoing alerts about NovAccess Global for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for NovAccess Global help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| NovAccess Global is way too risky over 90 days horizon | |
| NovAccess Global has some characteristics of a very speculative penny stock | |
| NovAccess Global appears to be risky and price may revert if volatility continues | |
| NovAccess Global currently holds 165.88 K in liabilities. NovAccess Global has a current ratio of 0.04, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist NovAccess Global until it has trouble settling it off, either with new capital or with free cash flow. So, NovAccess Global's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like NovAccess Global sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for NovAccess to invest in growth at high rates of return. When we think about NovAccess Global's use of debt, we should always consider it together with cash and equity. | |
| Net Loss for the year was (1.72 M) with profit before overhead, payroll, taxes, and interest of 752.56 K. | |
| NovAccess Global currently holds about 89.94 K in cash with (903.49 K) of positive cash flow from operations. | |
| Roughly 53.0% of the company outstanding shares are owned by insiders |
- Analyzing NovAccess Global's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether NovAccess Global's stock is overvalued or undervalued compared to its peers.
- Examining NovAccess Global's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating NovAccess Global's management team can have a significant impact on its success or failure. Reviewing the track record and experience of NovAccess Global's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of NovAccess Global's pink sheet. These opinions can provide insight into NovAccess Global's potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for NovAccess Pink Sheet Analysis
When running NovAccess Global's price analysis, check to measure NovAccess Global's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy NovAccess Global is operating at the current time. Most of NovAccess Global's value examination focuses on studying past and present price action to predict the probability of NovAccess Global's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move NovAccess Global's price. Additionally, you may evaluate how the addition of NovAccess Global to your portfolios can decrease your overall portfolio volatility.